<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sun C</submitter><funding>Brain Institute, University of Virginia</funding><funding>NIH HHS</funding><pagination>993-1006</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12927686</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>67(2)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Status epilepticus (SE) is second only to sudden unexpected death in epilepsy as a cause of seizure-related mortality. The progression of respiratory dysfunction during experimental SE remains poorly characterized. We investigated how pilocarpine-induced SE affects respiration in mice.&lt;h4>Methods&lt;/h4>We performed simultaneous plethysmographic, electroencephalographic, and electrocardiographic recordings in mice administered pilocarpine at 200, 240, or 280 mg/kg. We analyzed seizure progression, respiratory rate, ventilation, inspiratory/expiratory timing, and survival.&lt;h4>Results&lt;/h4>Higher pilocarpine doses resulted in shorter latency to SE and increased mortality. Across all doses, respiratory frequency and ventilation increased from baseline through early and establish</pubmed_abstract><journal>Epilepsia</journal><pubmed_title>Respiratory dysfunction and fatal apnea during pilocarpine-induced status epilepticus.</pubmed_title><pmcid>PMC12927686</pmcid><funding_grant_id>R37NS119012</funding_grant_id><funding_grant_id>R01 NS120945</funding_grant_id><pubmed_authors>Spera R</pubmed_authors><pubmed_authors>Ganabady H</pubmed_authors><pubmed_authors>Guduru B</pubmed_authors><pubmed_authors>Williamson JM</pubmed_authors><pubmed_authors>Sun C</pubmed_authors><pubmed_authors>Kapur J</pubmed_authors><pubmed_authors>Joshi S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Respiratory dysfunction and fatal apnea during pilocarpine-induced status epilepticus.</name><description>&lt;h4>Objective&lt;/h4>Status epilepticus (SE) is second only to sudden unexpected death in epilepsy as a cause of seizure-related mortality. The progression of respiratory dysfunction during experimental SE remains poorly characterized. We investigated how pilocarpine-induced SE affects respiration in mice.&lt;h4>Methods&lt;/h4>We performed simultaneous plethysmographic, electroencephalographic, and electrocardiographic recordings in mice administered pilocarpine at 200, 240, or 280 mg/kg. We analyzed seizure progression, respiratory rate, ventilation, inspiratory/expiratory timing, and survival.&lt;h4>Results&lt;/h4>Higher pilocarpine doses resulted in shorter latency to SE and increased mortality. Across all doses, respiratory frequency and ventilation increased from baseline through early and establish</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-09T12:06:58.176Z</modification><creation>2026-07-09T11:09:13.216Z</creation></dates><accession>S-EPMC12927686</accession><cross_references><pubmed>41137579</pubmed><doi>10.1111/epi.18674</doi></cross_references></HashMap>